(Stroke. 1997;28:844-849.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University (Richmond).
Correspondence to Dr Stuart W. Hoffman, Department of Pharmacology and Toxicology, Medical College of Virginia, PO Box 980613, 410 N 12th St, Room 754, Richmond, VA 23298. E-mail swhoffman{at}gems.vcu.edu
Background and Purpose Isoprostanes are generated by cyclooxygenase-independent free radical attack of arachidonic acid and are potent constrictors of the peripheral vasculature. Traumatic brain injury stimulates oxygen radical production and is associated with cerebral blood flow reduction. However, no specific vasoconstrictor has been identified as the cause of posttraumatic blood flow reduction. The purpose of this study was to determine whether isoprostanes constrict cerebral arterioles.
Methods The effects of 10-9 to
10-5 mol/L 8-iso-prostaglandin
F2
(8-iso-PGF2
),
8-iso-prostaglandin E2
(8-iso-PGE2), and prostaglandin
F2
(PGF2
) on pial
arteriolar diameter were measured in anesthetized rats using a
closed cranial window and in vivo microscopy.
Results All prostanoids produced vasoconstriction. Of
these, 8-iso-PGF2
produced the greatest
vasoconstriction (34%±2), followed by 8-iso-PGE2
(25%±4) and PGF2
(20%±2). After six
cerebrospinal fluid washouts of the cranial window, both
8-iso-PGF2
and
8-iso-PGE2treated vessels remained slightly constricted,
whereas the PGF2
-treated vessels returned to
control diameter. Coapplication of the semiselective
thromboxane A2/prostaglandin
H2 receptor antagonist SQ29548 completely
blocked the vasoconstriction induced by
8-iso-PGF2
and 8-iso-PGE2.
Conclusions Isoprostanes are potent constrictors of cerebral arterioles and appear to act at a receptor that is similar to the thromboxane A2/prostaglandin H2 receptor. Isoprostanes may play a role in the reduction of cerebral blood flow that occurs after brain injury and subsequent oxygen radical production.
Key Words: brain injuries cerebral circulation cerebral ischemia lipid peroxidation oxygen radical rats
This article has been cited by other articles:
![]() |
L. J. Janssen Isoprostanes and Lung Vascular Pathology Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 383 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci Reactive oxygen species: influence on cerebral vascular tone J Appl Physiol, February 1, 2006; 100(2): 739 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takeuchi, N. Miyata, M. Renic, D. R. Harder, and R. J. Roman Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R84 - R89. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wolfram, A. Oguogho, B. Palumbo, and H. Sinzinger Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF2{alpha} Eur J Heart Fail, March 2, 2005; 7(2): 167 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Yildirim, E. Kaptanoglu, K. Ozisik, E. Beskonakli, O. Okutan, M. F. Sargon, K. Kilinc, and U. Sakinci Ultrastructural changes in pneumocyte type II cells following traumatic brain injury in rats Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 523 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ospina, S. P. Duckles, and D. N. Krause 17{beta}-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H241 - H250. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hou, F. Gobeil Jr., A. M. Marrache, C. Quiniou, S. Brault, D. Checchin, S. G. Bernier, F. Sennlaub, J.-S. Joyal, D. Abran, et al. Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R928 - R935. [Abstract] [Full Text] [PDF] |
||||
![]() |
G G Koliakos, A G P Konstas, U Schlotzer-Schrehardt, G Hollo, I E Katsimbris, N Georgiadis, and R Ritch 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome Br. J. Ophthalmol., March 1, 2003; 87(3): 353 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Dillon, G. M. Lowe, D. Billington, and K. Rahman Dietary Supplementation with Aged Garlic Extract Reduces Plasma and Urine Concentrations of 8-Iso-Prostaglandin F2{alpha} in Smoking and Nonsmoking Men and Women J. Nutr., February 1, 2002; 132(2): 168 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hou, L. J. Roberts II, D. F. Taber, J. D. Morrow, K. Kanai, F. Gobeil Jr., M. H. Beauchamp, S. G. Bernier, G. Lepage, D. R. Varma, et al. 2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metabolite Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R391 - R400. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. WALSH, J. E. VAUGHAN, Y. WANG, and L. J. ROBERTS II Placental isoprostane is significantly increased in preeclampsia FASEB J, July 1, 2000; 14(10): 1289 - 1296. [Abstract] [Full Text] |
||||
![]() |
X. Hou, F. Gobeil Jr, K. Peri, G. Speranza, A. M. Marrache, P. Lachapelle, J. Roberts II, D. R. Varma, S. Chemtob, and E. F. Ellis Augmented Vasoconstriction and Thromboxane Formation by 15-F2t-Isoprostane (8-Iso-Prostaglandin F2{alpha}) in Immature Pig Periventricular Brain Microvessels • Editorial Comment Stroke, February 1, 2000; 31(2): 516 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. V. Dantas, R. Scivoletto, Z. B. Fortes, D. Nigro, and M. H. C. Carvalho Influence of Female Sex Hormones on Endothelium-Derived Vasoconstrictor Prostanoid Generation in Microvessels of Spontaneously Hypertensive Rats Hypertension, October 1, 1999; 34(4): 914 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Rzigalinski, K. A. Willoughby, S. W. Hoffman, J. R. Falck, and E. F. Ellis Calcium Influx Factor, Further Evidence It Is 5,6-Epoxyeicosatrienoic Acid J. Biol. Chem., January 1, 1999; 274(1): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lahaie, P. Hardy, X. Hou, H. Hassessian, P. Asselin, P. Lachapelle, G. Almazan, D. R. Varma, J. D. Morrow, L. J. Roberts II, et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2alpha on retinal vessels Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1406 - R1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mallat, I. Philip, M. Lebret, D. Chatel, J. Maclouf, and A. Tedgui Elevated Levels of 8-iso-Prostaglandin F2{alpha} in Pericardial Fluid of Patients With Heart Failure : A Potential Role for In Vivo Oxidant Stress in Ventricular Dilatation and Progression to Heart Failure Circulation, April 28, 1998; 97(16): 1536 - 1539. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |